Treatment planning using a dose–volume feasibility search algorithm
Data up to Jan 2025
Total Citations Per Year
Abstract
References (21)
Tolerance of normal tissue to therapeutic irradiation
1991 • 4,329 citations
Complication Probability as Assessed from Dose-Volume Histograms
1985 • 1,133 citations
The Relaxation Method for Linear Inequalities
1954 • 562 citations
The Relaxation Method for Linear Inequalities
1954 • 454 citations
Dose-volume histograms
1991 • 355 citations
Optimisation of conformal radiotherapy dose distribution by simulated annealing
1989 • 341 citations
Clinically relevant optimization of 3-D conformal treatments
1992 • 279 citations
Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture
1991 • 232 citations
Conventional vs. conformal radiotherapy for prostate cancer: Preliminary results of dosimetry and acute toxicity
1996 • 195 citations
A photon dose distribution model employing convolution calculations
1985 • 157 citations
Treatment plan optimization using linear programming
1991 • 150 citations
Optimizing the planning of intensity-modulated radiotherapy
1994 • 131 citations
Cyclic subgradient projections
1982 • 107 citations
A new technique for radiotherapy planning using quadratic programming
1976 • 99 citations
Random sampling for evaluating treatment plans
1990 • 84 citations
A constrained least‐squares optimization method for external beam radiation therapy treatment planning
1984 • 75 citations
Calculation of photon dose distributions in an inhomogeneous medium using convolutions
1986 • 74 citations
Practical considerations in using calculated healthy-tissue complication probabilities for treatment-plan optimization
1999 • 45 citations
Constrained simulated annealing for optimized radiation therapy treatment planning
1990 • 40 citations
Evaluation and scoring of radiotherapy treatment plans using an artificial neural network
1996 • 34 citations
Relationship of prostate biopsy status to radiotherapy dose, PSA nadir level and outcome in participants of a randomized dose escalation trial for prostate cancer
2001 • 4 citations